NATALIE MOLNAR: Open Payments
NPI 1265117485 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,875 in 131 payments from 30 companies in 2025. Trend: 2023 $749 · 2024 $1,675 · 2025 $2,875
Food & beverage: $2,875
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $587 |
| Amgen Inc. | 17 | $318 |
| ABBVIE INC. | 14 | $289 |
| PFIZER INC. | 10 | $254 |
| Novo Nordisk Inc | 15 | $211 |
| Otsuka America Pharmaceutical, Inc. | 6 | $134 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $111 |
| GlaxoSmithKline, LLC. | 5 | $106 |
| ViiV Healthcare Company | 5 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
Products named: UBRELVY, AIRSUPRA, REXULTI, REPATHA, ZAVZPRET, TEZSPIRE, JARDIANCE, BREZTRI.
Industry payments across CO — which companies pay providers there.
